CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy
- PMID: 22019250
- DOI: 10.1016/j.jcv.2011.09.018
CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy
Abstract
Background: The level of HIV-1 integrated DNA in CD4 T cells was reported to predict the evolution of untreated HIV-1 infection independently of CD4 cell counts or plasma HIV-1 RNA levels. However, the relevance of reservoir level while on efficient antiretroviral therapy (ART) is still unknown.
Objectives: To evaluate factors that may contribute to the establishment and maintenance of HIV-1 reservoir size in ART-treated HIV-1-infected adults with complete suppression of viremia.
Study design: 35 subjects receiving ART with plasma HIV-1 RNA below the limit of detection for an average duration of 3.2 years were studied. A highly sensitive PCR was used to assess HIV-1 integrated DNA levels in sorted CD4 T cells.
Results: The mean HIV-1 integrated DNA was 300±7copies/10(6) CD4 cells (range 10-1408). In univariate analysis, the levels of HIV-1 proviral DNA appeared to be independent of duration of HIV-1-infection, duration on ART, time since HIV-1 viral load was undetectable, delay between HIV-1 infection and starting ART, or viral load before starting ART. Conversely, CD4 T cell nadir, CD4/CD8 ratio and, to lesser degree, CD4 T cell counts were inversely associated with HIV-1 proviral DNA levels. In multivariate analysis, only CD4 T cell nadir significantly predicted levels of HIV-1 proviral DNA (P=0.025).
Conclusions: CD4 T cell nadir strongly predicted reservoir size independently of other factors in HIV-1-infected adults with complete suppression of viremia. Collectively, these results indicate that the extent of CD4 T cell depletion before ART drives the size of the viral reservoir after prolonged therapy.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.J Clin Virol. 2005 Dec;34(4):257-67. doi: 10.1016/j.jcv.2005.02.015. Epub 2005 Apr 18. J Clin Virol. 2005. PMID: 16286049
-
Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.J Infect Dis. 2005 May 15;191(10):1670-9. doi: 10.1086/429670. Epub 2005 Apr 5. J Infect Dis. 2005. PMID: 15838794
-
Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.AIDS. 2012 Jan 14;26(2):167-74. doi: 10.1097/QAD.0b013e32834e8955. AIDS. 2012. PMID: 22089379 Clinical Trial.
-
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.AIDS. 2012 Jun 19;26(10):1261-8. doi: 10.1097/QAD.0b013e328353f3f1. AIDS. 2012. PMID: 22472858 Review.
-
[Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:17-22. doi: 10.1016/s0213-005x(08)76568-6. Enferm Infecc Microbiol Clin. 2008. PMID: 19572421 Review. Spanish.
Cited by
-
Association of serum vitamin B12 with immuno-hematological parameters in treatment-naive HIV positive cases.J Family Med Prim Care. 2022 Jul;11(7):3784-3789. doi: 10.4103/jfmpc.jfmpc_2490_21. Epub 2022 Jul 22. J Family Med Prim Care. 2022. PMID: 36387710 Free PMC article.
-
Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy.HIV Med. 2019 Jan;20(1):63-68. doi: 10.1111/hiv.12675. Epub 2018 Sep 30. HIV Med. 2019. PMID: 30270543 Free PMC article. Clinical Trial.
-
Dolutegravir plus lamivudine versus efavirenz plus tenofovir disoproxil fumarate and lamivudine in antiretroviral-naive adults with HIV-1 infection.BMC Infect Dis. 2022 Jan 4;22(1):17. doi: 10.1186/s12879-021-06991-y. BMC Infect Dis. 2022. PMID: 34983415 Free PMC article.
-
Targeted plasma proteomics identifies MICA and IL1R1 proteins associated with HIV-1 reservoir size.iScience. 2023 Mar 22;26(4):106486. doi: 10.1016/j.isci.2023.106486. eCollection 2023 Apr 21. iScience. 2023. PMID: 37091231 Free PMC article.
-
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.EBioMedicine. 2015 Jun 27;2(8):874-83. doi: 10.1016/j.ebiom.2015.06.019. eCollection 2015 Aug. EBioMedicine. 2015. PMID: 26425694 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials